Legislation recently introduced in the U.S. House of Representatives would add the Zika virus to the list of diseases in the Food and Drug Administration’s (FDA) priority review voucher (PRV) program. The Senate HELP Committee has also recently advanced...
Filed under: Global Health, Research, Featured, Drugs and Medical Technology, Ebola, FDA, Congress, priority review, Zika, outbreaks, pandemic